Harry J. Gould, III MD, PhD
Once again, it is time to begin a brand new year. Since I stepped into the role of president of the Southern Pain Society, we as a society have experienced moments of promise with the release and early encouraging responses to vaccines to thwart the COVID-19 pandemic. These advances fostered the hope of resuming in person meetings, but the resurgence of the pandemic due to the delta variant dictated
With the FDA’s blessing in mid-December on the administration of vaccines for COVID-19 and subsequent indications of downward trends in the rate of infections, hospitalizations and deaths associated with the virus came a feeling that the worst of the pandemic was past and we were on a return path to recover normalcy…
Approximately 9.6% of Americans have a personality disorder.1,2 These are common conditions, and all medical professionals encounter patients with such disorders in their practice. Early identification of this group of patients is ideal. In the following we discuss how patients with these psychiatric conditions may present to an outpatient pain clinic…
Harry J. Gould, III, MD, PhD On June 26, 2021, Johnson & Johnson confirmed that in 2020, as part of a $230M settlement with the State of New York, they discontinued promotion and distribution of opioid products in the State of New York. The settlement was made in response to efforts to mitigate the unprecedented […]
Olivia Lee and Lawrence Robbins, MD Introduction Over 325 million doses of COVID-19 vaccines have been distributed in the United States, and much of the country is looking forward to a return to normalcy. For many, the widespread access to vaccines signaled the pandemic’s defeat, but for millions of COVID-19 survivors, the sequelae following acute […]
ANA2021’s Virtual Annual Meeting is set for October 17-19 with an Opening Symposium on October 16 and registration is now open! All full registrations include access to the ANA2021 Meeting Recordings package, ensuring you won’t miss out on the latest neurological research even if your schedule should change. Registration also includes complimentary access to the SIG Series […]
Harry J. Gould, III, MD, PhD Pain occurs in both acute and chronic forms. In its acute form, pain is a modality that is essential for survival and is the signal that most frequently brings people to the attention of the healthcare professional. Many cases of simple acute pain are readily treated without difficulty by […]
The CGRP Monoclonal Antibodies for Migraine Are a Prime Example Lawrence Robbins, M.D. This letter is in response to an excellent July, 2020 article “Migraine and CGRP Monoclonal Antibodies: A Review of Cardiovascular Side Effects and Safety Profile” (Boldig and Butala) in the International Journal of Neurology and Neurotherapy. (1) There are a plethora of […]
A year ago, the United States was in the midst of understanding and dealing with the complexities of the “Opioid Epidemic”, what until then had been considered the greatest healthcare crisis in U.S. history. Although improvements in some aspects of the crisis were starting to be realized as a result of the development of best evidence-based practice guidelines and the implementation […]
Lawrence Robbins, MD Individuals suffering from chronic pain often have psychiatric comorbidities. For instance, among those with chronic migraine approximately 9% fit into the bipolar spectrum. (1) This article discusses a representative case of a patient with chronic migraine and bipolar disorder as well as epilepsy and irritable bowel syndrome. Caitlin is a 28-year-old female […]
